Massalia Therapeutics
PrivateLast Round
Grant
Oct 14, 2025
Total Funding Raised
$650,000
Company Overview
Massalia Therapeutics operates in Healthcare & Life Sciences and is based in Marseille. Its latest recorded funding round was a Grant round in October 2025.
Massalia Therapeutics is a biotechnology company that develops therapeutic platforms for the treatment of complex conditions intersecting oncology, fibrosis, and neovascularization.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Massalia Therapeutics Comparables
Compare Massalia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kekkan Biologics | 76% | |
| SPIMA Therapeutics | 75% | |
| Elikya Therapeutics | 70% |
For institutional investors. Book with your work email.
Massalia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 14, 2025 | ||||
| Seed | May 19, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Massalia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SATT Sud-Est | Seed |
| Landmark BioVentures AG | Seed |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 43% MoM, reaching 1K.
- Oct 14, 2025
$650K grant received from Bpifrance.
For institutional investors. Book with your work email.
Massalia Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Massalia Therapeutics's valuation, stock price, and market status.
Is Massalia Therapeutics a public or private company?
Massalia Therapeutics is a private company.
What is the current stock price of Massalia Therapeutics?
Massalia Therapeutics is a private company, so its shares have no public market price. Caplight tracks Massalia Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Massalia Therapeutics worth (valuation)?
Valuation information for Massalia Therapeutics is not publicly available.
Can I buy Massalia Therapeutics stock?
Massalia Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Massalia Therapeutics's last funding round?
Massalia Therapeutics's most recent funding round was Grant on October 14, 2025.
Who are the main investors in Massalia Therapeutics?
Key investors in Massalia Therapeutics include Landmark BioVentures AG.
Will Massalia Therapeutics IPO soon?
No public IPO plans have been announced for Massalia Therapeutics.
How can I track Massalia Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Massalia Therapeutics's shares on secondary markets.